With in vivo models of metabolic disorders, LGG regulates tissue gene expression of inflammatory cytokines, such as NF-κB-p65, iNOS, TNF-α, IL-1β, and COX-2 [106,107]. This evidence concerns the gene NFKB1 and metabolic disease.